During the past decade, Georgetown University Medical Center - Department of Rheumatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georgetown University Medical Center - Department of Rheumatology" are "Pulmonary Hypertension" (2 trials), "Acute Interstitial Pneumonitis" (1 trials), "Connective Tissue Disease-Associated Pulmonary Arterial Hypertension" (1 trials), "Cryptogenic Organizing Pneumonia" (1 trials) and "Desquamative Interstitial Pneumonia" (1 trials). Many other conditions were trialed in "Georgetown University Medical Center - Department of Rheumatology" in a lesser frequency.

Most popular intervention types in "Georgetown University Medical Center - Department of Rheumatology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bardoxolone methyl" (2 trials), "Iloprost Injection, for intravenous use" (2 trials), "Placebo IV infusion" (2 trials), "Bardoxolone methyl capsules" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown University Medical Center - Department of Rheumatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Georgetown University Medical Center - Department of Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Georgetown University Medical Center - Department of Rheumatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown University Medical Center - Department of Rheumatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".